- Home
- TR vs ZLAB Comparison
TR vs ZLAB Comparison
Compare TR & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TR | ZLAB |
|---|---|---|
| Founded | 1896 | 2013 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Specialty Foods | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.2B |
| IPO Year | N/A | 2017 |
Fundamental Metrics
Financial Performance| Metric | TR | ZLAB |
|---|---|---|
| Price | $37.46 | $19.56 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $57.22 |
| AVG Volume (30 Days) | 135.0K | ★ 849.1K |
| Earning Date | 10-23-2025 | 11-06-2025 |
| Dividend Yield | ★ 0.96% | N/A |
| EPS Growth | ★ 0.79 | N/A |
| EPS | ★ 1.28 | N/A |
| Revenue | ★ $729,620,000.00 | $441,629,000.00 |
| Revenue This Year | N/A | $30.20 |
| Revenue Next Year | N/A | $34.71 |
| P/E Ratio | $29.26 | ★ N/A |
| Revenue Growth | 0.34 | ★ 24.14 |
| 52 Week Low | $28.67 | $19.40 |
| 52 Week High | $44.27 | $44.34 |
Technical Indicators
Market Signals| Indicator | TR | ZLAB |
|---|---|---|
| Relative Strength Index (RSI) | 41.69 | 25.39 |
| Support Level | $37.21 | $19.40 |
| Resistance Level | $38.02 | $20.47 |
| Average True Range (ATR) | 0.98 | 0.54 |
| MACD | -0.08 | 0.25 |
| Stochastic Oscillator | 14.33 | 8.06 |
Price Performance
Historical ComparisonAbout TR Tootsie Roll Industries Inc.
Tootsie Roll Industries Inc manufactures and sells confectionery products. Notable varieties include Tootsie Roll and Tootsie Pops, Charms, Blow-Pops, Dots, Junior Mints, Sugar Daddy and Sugar Babies, Andes, Dubble Bubble, Razzles among others. The company sells its products to wholesale distributors and directly to retail stores. Geographically, it generates a majority of its revenue from the United States and rest from Canada, Mexico and other regions.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.